A few weeks ago, I mentioned that I had enrolled in a trial using Docetaxel and Radium 223. Fifteen minutes into the first infusion of Docetaxel, I had a reaction that affected my breathing and dropped my blood pressure and pulse, but cleared after stopping the infusion and then reducing the flow rate.
On the second dose, I had the same reaction only 5 minutes in, even with reduced flow rate and additional Decadron 3 days prior. Needless to say, I washed out of the trial as not tolerating the Docetaxel.
While this is disappointing, I will continue with Xofigo (Radium 223) as soon as it clears insurance.
What is the likelihood that I wiped out the entire class of taxanes by having reactions to Docetaxel? I'm sure that before long, I will need chemo for non-bone tumors, and I'm looking at options.